KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ: 307750)

Market Cap	202.16B
Revenue (ttm)	133.27B
Net Income (ttm)	5.35B
Shares Out	49.07M
EPS (ttm)	65.19
PE Ratio	63.20
Forward PE	n/a
Dividend	10.00 (0.24%)
Ex-Dividend Date	n/a

Volume	10,592
Open	4,120.00
Previous Close	4,120.00
Day's Range	4,120.00 - 4,195.00
52-Week Range	4,000.00 - 7,110.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About KUKJEON PHARMACEUTICAL

KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic materials, such as antistatic agents, monomers and polymers with low dielectric constant, and UV curing agents; low-resistance electrolyte, phosphine, sila...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1972
• Employees: 175
• Stock Exchange: KOSDAQ
• Ticker Symbol: 307750

Financial Performance

In 2023, KUKJEON PHARMACEUTICAL's revenue was 122.00 billion, an increase of 17.63% compared to the previous year's 103.71 billion. Earnings were 4.82 billion, a decrease of -46.09%.